Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups
(Q93911529)
scientific article published in August 1998
scientific article published in August 1998
Language:
Current Data About
Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups
other details
| description | scientific article published in August 1998 |
External Links
| (P356) |
10.1016/S0041-1345(98)00571-5
|
| (P698) |
9723424
|